U.S. Fertility Supplements Market Set for Strong Growth to USD

Fertility Supplements 2026-2033

AUSTIN, Texas and TOKYO
The global Fertility Supplements Market size reached US$ 2.23 Billion in 2024 from US$ 2.06 Billion in 2023 and is expected to reach US$ 4.74 Billion by 2033, growing at a CAGR of 8.8% during the forecast period 2025-2033.

DataM Intelligence, a market intelligence and consulting firm, has released a new report titled “fertility supplements Market – 2026 – 2033,” which indicates a definite shift from pilot R&D projects to commercial projects in Europe, Asia-Pacific, North America and Middle East & Africa.

The fertility supplements market’s strong growth in the U.S. is fueled by rising infertility awareness, innovative doctor-led partnerships like US Fertility’s collaboration with Luminary Vitamins combining tech and targeted nutraceuticals, while in Japan supportive government policies and increasing high-quality supplement adoption are boosting demand for reproductive health products.

Download your exclusive sample report today: (corporate email gets priority access):https://www.datamintelligence.com/download-sample/fertility-supplements-market?prtk

Key Industry Development

United States

✅ U.S. Fertility Supplements Market Set for Strong Growth to USD 1.27 Billion by 2033, Led by North America’s 34.2% Global Share | Key Players – Eurho Vital, Fairhaven Health, Exeltis USA

✅ February 2025: Theralogix expanded its physician-exclusive reproductive health portfolio with an upgraded preconception supplement line formulated with higher bioavailable folate and choline, targeting women undergoing assisted reproductive treatments across major U.S. fertility clinics.

✅ January 2025: Pink Stork introduced a new fertility support gummy enriched with myo-inositol and CoQ10, designed for women managing PCOS-related ovulatory concerns, strengthening its direct-to-consumer footprint in the U.S. fertility supplements segment.

✅ January 2025: Fairhaven Health launched an advanced male fertility formulation combining antioxidants, L-carnitine, and zinc, aimed at improving sperm motility and count amid rising demand for male reproductive health solutions in the United States.

Asia Pacific / Japan

✅ February 2025: Otsuka Pharmaceutical expanded its women’s health nutraceutical offerings in Japan with a fertility-focused supplement incorporating iron, folate, and traditional Kampo-inspired botanical extracts, targeting delayed childbearing demographics.

✅ January 2025: Fancl Corporation launched a new preconception support supplement fortified with DHA and antioxidant blends, responding to growing demand among Japanese women aged 30-40 seeking nutritional fertility optimization.

✅ January 2025: Yakult Honsha expanded into reproductive wellness with a probiotic-based supplement formulated to support vaginal microbiome balance, aligning with Japan’s increasing focus on preventive fertility care and microbiota research.

Strategic Merges & Aquisitions:

✅ In February 2025, Nestlé Health Science announced the acquisition of a majority stake in Theralogix. While financial terms were not publicly disclosed, the transaction was officially confirmed by both companies. The acquisition strengthens Nestlé Health Science’s position in the fertility supplements market by expanding its portfolio of clinically backed prenatal and preconception nutritional products, particularly in North America.

✅ In January 2025, Exeltis, part of the Insud Pharma group, completed the acquisition of selected women’s health nutraceutical assets from Procare Health. The deal value was not disclosed. This acquisition enhances Exeltis’ reproductive health and fertility supplement portfolio across Europe and Latin America, supporting its strategy to integrate pharmaceuticals with evidence-based nutraceutical solutions.

✅ In March 2025, CooperCompanies, through its fertility-focused division CooperSurgical, acquired complementary reproductive health supplement distribution assets in the U.S. market. Financial details were not publicly released. The acquisition aligns with CooperCompanies’ broader fertility ecosystem strategy, integrating supplements alongside assisted reproductive technologies (ART) solutions to provide comprehensive patient support.

Fairhaven Health – A global leader with 18.6% market share, Fairhaven Health dominates through clinically formulated fertility nutrition for both men and women. Its strong brand recognition, evidence-backed products like FertilAid and widespread retail + online presence underpin its leading position in reproductive wellness.

Vitabiotics Ltd. – Holding around 15.4% of the market, Vitabiotics excels in vitamin-mineral formulations essential for preconception and prenatal health. Its trusted portfolio (e.g., Pregnacare) and robust pharmacy and retail distribution enhance consumer trust and drive adoption globally.

Orthomol – With about 13.1% market share, Orthomol leverages deep micronutrient science and premium orthomolecular formulations. High demand in Europe and medical-recommended fertility blends strengthen its market position in reproductive support and comprehensive nutrient therapy.

Ovaterra – Accounting for 10.7% share, Ovaterra focuses on targeted fertility supplements for both genders. Practitioner-backed formulations and growing e-commerce reach drive its adoption, especially among consumers seeking purpose-driven reproductive health solutions.

Exeltis USA, Inc. – Holding roughly 9.2% of the market, Exeltis USA stands out with pharmaceutical-grade nutritional products and strong emphasis on women’s reproductive health. Its reputation among healthcare professionals and presence in clinical care channels enhance its competitive market position.

“Secure your 30% discount – get this report before the offer expires.”

:https://www.datamintelligence.com/buy-now-page?report=fertility-supplements-market?prtk (Purchase 2 or more Repots and get 50% Discount)

Market Segmenatation-

1. Ingredient Type Segmentation

In both the United States and Japan, fertility supplements are segmented by ingredient types, typically including natural, synthetic, and blends of natural and synthetic formulations. In the U.S. market, synthetic/blend products currently generate the largest revenue share with natural formulations growing fastest due to rising demand for clean‐label and plant‐based supplements that support reproductive health, while in Japan the synthetic/blend segment also dominates revenue but there is strong emerging interest in natural ingredient products aligned with local consumer preferences.

2. Product or Type Segmentation

Segmentation by product or type in both countries covers common supplement formats such as vitamins and minerals, herbal and botanical products, amino acids, probiotics, and combination packs. In the U.S., vitamins and minerals dominate as core fertility support supplements recommended by healthcare professionals and widely sold through retail and online channels, reflecting consumer awareness of nutritional roles in fertility. Japan’s market also includes these product types, with soft gels, tablets, and capsules being significant formats, and consumer preferences leaning toward scientifically backed ingredients that emphasize purity and quality.

3. End‐User or Consumer Segmentation

End‐user segmentation in the U.S. differentiates women‐focused, men‐focused, couple‐focused, and healthcare provider channels, showing broad usage by women but increasing male segment interest as male fertility awareness grows. Japanese segmentation similarly considers men and women as distinct consumer groups, with women historically representing larger market share but male usage expanding as reproductive health awareness increases across genders.

4. Distribution Channel Segmentation

Distribution segmentation in the U.S. spans online retail, pharmacies, health food stores, specialty outlets, and direct‐to‐consumer platforms, with online and D2C channels gaining prominence as a convenient way to access fertility supplements. In Japan, the distribution mix includes over‐the‐counter (OTC) and prescribed channels, where OTC remains important for self‐care purchases but prescribed channels are significant for clinical recommendations associated with fertility treatments.

5. Formulation/Format Segmentation

Fertility supplements in both markets are segmented by formulation formats like capsules, tablets, powders, liquids, and soft gels. In the U.S., capsules and tablets are highly popular due to consumer familiarity and ease of dosing, while Japan also features similar format choices with soft gels and capsules widely used and tailored to local preferences for high‐quality delivery systems.

Market Drivers:

• Rising Prevalence of Infertility Conditions: The increasing incidence of infertility among reproductive‐age individuals in both the US and Japan is a central growth driver, as more couples seek supportive, non‐invasive solutions to enhance fertility.

• Consumer Shift to Natural and Clean‐Label Formulations: US consumers are increasingly selecting fertility supplements with natural, organic or “clean label” ingredients due to perceived safety and health advantages-a trend that is propelling product innovation and category adoption.

• Awareness of Diet and Lifestyle Impact on Reproductive Health: Expanded education on the role of nutrition, antioxidants, and specific vitamins/minerals in reproductive health has boosted the demand for fertility supplements in both countries, making dietary support a key consideration for preconception care.

• Expansion of Online & D2C Distribution Channels: In the US, direct‐to‐consumer (D2C) models, subscription replenishment services, and e‐commerce accessibility have lowered barriers to purchase and supported consistent supplementation habits.

• Growing Preference for Personalized and Advanced Formulations: Technological advancements in supplement research, including personalized blends and clinically‐oriented formulations, are driving higher product interest and loyalty among US buyers seeking targeted reproductive support.

• Low Birth Rates and Aging Population in Japan: Japan’s demographic challenges-including a declining birth rate and an aging population-are creating increased emphasis on fertility maintenance and preservation strategies, which supports demand for fertility supplements tailored to older reproductive age groups.

• Interest in Herbal and Traditional Ingredient Profiles: Fertility supplements featuring herbal extracts and traditional botanicals resonate particularly well in Japan, where consumer preference for high‐quality, culturally familiar ingredients (e.g., ginseng) adds to market growth momentum.

Regional insights:

North America: 34.2% (Largest share – driven by high consumer awareness and advanced healthcare infrastructure; within this, the United States accounts for ~78.6% of the North American fertility supplements market, meaning the US itself contributes roughly ~26.9% of the global market)

Europe: 26.9% (Strong adoption supported by preventive healthcare policies and high product uptake; key European markets include Germany, UK, and France)

Asia Pacific: ~22% (Rapid growth driven by rising infertility awareness and expanding online retail; Japan is a significant part of this region’s market – adoption is increasing due to low birth rates and emphasis on reproductive health, though standalone

Get Customization in the report as per your requirements:https://www.datamintelligence.com/customize/fertility-supplements-market?prtk

Request for 2 Days FREE Trial Access:

https://www.datamintelligence.com/reports-subscription?pratik

✅ Competitive Landscape

✅ Technology Roadmap Analysis

✅ Sustainability Impact Analysis

✅ KOL / Stakeholder Insights

✅ Consumer Behavior & Demand Analysis

✅ Import-Export Data Monitoring

✅ Live Market & Pricing Trends

Have a look at our Subscription Dashboard:

https://www.youtube.com/watch?v=x5oEiqEqTWg

Company Name: DataM Intelligence

Contact Person: Sai Kiran

Email: Sai.k@datamintelligence.com

Phone: +1 877 441 4866

Website: https://www.datamintelligence.com

About DataM Intelligence

DataM Intelligence is a renowned provider of market research, delivering deep insightsthrough pricing analysis, market share breakdowns, and competitive intelligence. Thecompany specializes in strategic reports that guide businesses in high-growth sectors suchas nutraceuticals and AI-driven health innovations.

To find out more, visit https://www.datamintelligence.com/ or follow us on Twitter,LinkedIn and Facebook.

This release was published on openPR.